Cargando…

P1537: MORTALITY AND BURDEN OF POST-COVID-19 SYNDROME HAVE REDUCED WITH TIME ACROSS SARS-COV-2 VARIANTS IN HAEMATOLOGY PATIENTS

Detalles Bibliográficos
Autores principales:	Willan, John, Agarwal, Gaurav, Bienz, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430385/ http://dx.doi.org/10.1097/01.HS9.0000973024.65133.7a

Ejemplares similares

1537 The AHKER Study: Assessing HIV Knowledge of Emergency Residents
por: Maso, Kristi, et al.
Publicado: (2014)

P1640: REAL-WORLD SUPPORTIVE EVIDENCE FOR THE 4D-DVT ALGORITHM: ADJUSTING D-DIMER THRESHOLDS FOR INITIAL AND FOLLOW-UP IMAGING OF PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS BY CLINICAL PROBABILITY
por: Willan, John, et al.
Publicado: (2023)

P1537: HEREDITARY ANEMIA CAUSED BY MULTILOCUS INHERITANCE OF PIEZO1, SLC4A1 AND ABCB6 MUTATIONS: A DIAGNOSTIC AND THERAPEUTIC CHALLENGE.
por: Rosato, B. E., et al.
Publicado: (2022)

Nanopore Genome Sequencing and Variant Analysis of the Susceptible Candida auris Strain L1537/2020, Salvador, Brazil
por: de Jong, Auke W., et al.
Publicado: (2021)

1537. Incidence, Reinfection, and Discrepancy Between Site Positivity and Reported Sexual Practice of Sexually Transmitted Infections in HIV-Positive Adolescents and Young Adults in Atlanta, GA
por: Loerinc, Leah, et al.
Publicado: (2020)

1537. Multicenter Study with Therapeutic Drug Monitoring (TDM) of Voriconazole (VRCZ) in Japanese Patients
por: Ueda, Takashi, et al.
Publicado: (2019)

P1609: VERY LOW MORTALITY IN DOUBLE VACCINATED IMMUNOCOMPROMISED HAEMATOLOGY PATIENTS INFECTED WITH SARS-COV-2.
por: Shaw, B., et al.
Publicado: (2022)

P1547: CLINICAL CHARACTERISTICS OF PATIENTS WITH PROLONGED VIRAL SHEDDING OF OMICRON VARIANT IN HAEMATOLOGICAL DISEASE
por: Ikeda, Daisuke, et al.
Publicado: (2023)

1537. Reactivation of Latent Cytomegalovirus Infection in Patients with Rheumatologic Disease: A Case–Control Study
por: Gardiner, Bradley, et al.
Publicado: (2018)

Outcome of haematology patients admitted to intensive care in a tertiary centre: primary haematological diagnosis, recent chemotherapy and bone marrow transplantation are not associated with outcome
por: José, R, et al.
Publicado: (2011)

Patterns of infection and impact on outcome in haematology patients admitted to intensive care
por: José, R, et al.
Publicado: (2011)

Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
por: Pugh, R, et al.
Publicado: (2013)

P1615: AN ANALYSIS ACROSS ABO BLOOD GROUPS IN PATIENTS WITH COVID-19 INFECTION AND CORRELATION WITH HAEMATOLOGICAL BIOMARKERS, A SINGLE CENTRE STUDY
por: Shokr, H., et al.
Publicado: (2022)

Prediction of hospital mortality by classification trees and smoothing splines in patients with haematological malignancies admitted to the ICU
por: Verplancke, T, et al.
Publicado: (2009)

P631 Community respiratory virus infections in patients with haematological malignancies
por: Chebotkevich, V., et al.
Publicado: (2007)

P1570: SARS-COV-2 HUMORAL AND CELLULAR VACCINATION RESPONSE IN PATIENTS WITH LYMPHOID HAEMATOLOGICAL MALIGNANCIES
por: Boerenkamp, L. S., et al.
Publicado: (2022)

Is intensive care beneficial for patients with haematologic malignancies?
por: Nyunga, M, et al.
Publicado: (2010)

Prognosis of patients with haematological malignancies admitted to the ICU
por: Geerse, DA, et al.
Publicado: (2008)

P1538: MULTIDRUG RESISTANT BACTERIAL COLONIZATION AND RELATED BLOODSTREAM INFECTIONS IN FEBRILE HAEMATOLOGIC PATIENTS: EPIDEMIOLOGY AND OUTCOME
por: Cattaneo, Chiara, et al.
Publicado: (2023)

Prediction of hospital mortality by support vector machine versus logistic regression in patients with a haematological malignancy admitted to the ICU
por: Verplancke, T, et al.
Publicado: (2008)

P1536: SARS-COV-2 INFECTIONS IN PATIENTS WITH HAEMATOLOGIC MALIGNANCIES: EFFECT OF VACCINATION AND THE DEVELOPMENT OF HYBRID IMMUNITY
por: Haggenburg, Sabine, et al.
Publicado: (2023)

Outcome prediction in haematological patients requiring admission to the ICU
por: Gopal, S, et al.
Publicado: (2011)

Advance care planning in critically ill haematology patients
por: Metaxa, V, et al.
Publicado: (2014)

Outcome of patients with haematological malignancy admitted to the general ICU
por: Ketchley, I, et al.
Publicado: (2008)

Haematological alterations in malaria-infected refugees in South Africa
por: Tsoka-Gwegweni, Joyce, et al.
Publicado: (2014)

Correlation between tobacco control policies and mortality of haematological cancers across Europe: An ecological study
por: Mehta, Dipal, et al.
Publicado: (2021)

P-085: THE MORBIDITY AND MORTALITY OF SICKLE CELL DISEASE PATIENTS IN THE HAEMATOLOGY DEPARTMENT OF THE IGNACE DEEN HOSPITAL, CONAKRY HOSPITAL AND UNIVERSITY CENTRE
por: M., DIAKITE, et al.
Publicado: (2022)

Thrombosis among 1537 patients with JAK2(V617F)‐mutated myeloproliferative neoplasms: Risk factors and development of a predictive model
por: Zhang, Yuhui, et al.
Publicado: (2020)

Haematological measurements and iron levels in HIV-infected Gambian subjects
por: Bah, Gibril, et al.
Publicado: (2006)

Outcome of patients with metastatic cancer or haematological malignancy in intensive care
por: Meynaar, I, et al.
Publicado: (2009)

Predictors of outcome in patients with haematological malignancies admitted to critical care
por: Tridente, A, et al.
Publicado: (2014)

BURDEN OF CARE IN PATENTS OF CHILDREN SUFFERING FROM HAEMATOLOGICAL MALIGNANCIES
por: Kulhara, Parmanand, et al.
Publicado: (1998)

BURDEN OF CARE IN PARENTS OF CHILDREN SUFFERING FROM HAEMATOLOGICAL MALIGNANCIES
por: Ashok, M.V., et al.
Publicado: (1998)

P846: GENERATION OF A FIRST-IN-CLASS INHIBITOR FOR THE MASTER ONCOREGULATOR HNRNP K IN HAEMATOLOGICAL MALIGNANCIES
por: Otero-Sobrino, Álvaro, et al.
Publicado: (2023)

P1549: HIGH PREVALENCE OF RESPIRATORY SYNCYTIAL VIRUS IN HAEMATOLOGICAL PATIENTS AFTER COVID19 WAVES.
por: Farina, Francesca, et al.
Publicado: (2023)

Outcome of critically ill patients with haematological malignancy admitted to the ICU as an emergency
por: Lofaro, T, et al.
Publicado: (2013)

Haematological patients admitted to icu: differences between survivors and non-survivors
por: Lujan Varas, J, et al.
Publicado: (2015)

Transformation and Overexpression of Primary Cell Wall Synthesis-Related Zinc Finger Gene Gh_A07G1537 to Improve Fiber Length in Cotton
por: Razzaq, Abdul, et al.
Publicado: (2021)

Non-transplant patients with haematologic malignancies have better survival outcome than recipients of haematopoietic stem cell transplant (HSCT) after admission to intensive care unit (ICU)
por: Corcia Palomo, Y, et al.
Publicado: (2015)

P1605: OUTCOME OF SARS-COV-2 INFECTION IN HAEMATOLOGICAL CANCER PATIENTS (PTS) IN TWO DIFFERENT PANDEMIC PHASES AT A SINGLE CENTRE
por: Rodrigues, R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tgr1p2iu6fs8tp87n3ovt6erjl